A survey showed 67.3% of patient advocacy organizations received industry funding, while 11.9% received more than half of their funding from industry.
All articles by Chad Ulman, AIA, NCARB, LEED, AP BD+C
Intrathecal dosing of neural progenitors appears to be safe and well tolerated in patients with progressive multiple sclerosis.
Investigational agent has the potential to repair damaged myelin sheath and restore function in patients with secondary-progressive multiple sclerosis.
Patients with MS were likely to experience relapses for the first time or relapse continuation between the ages of 27 and 47 years.
Glucocerebrosidase gene mutation has been found to be strongly associated with REM sleep behavior disorder.
Investigators aimed to quantify functional connectivity differences in patients with MS and to determine the association between these alterations and cognitive performance.
An altered functional network involving the ipsilateral and contralateral hippocampal areas was associated with cognitive impairment in patients with temporal lobe epilepsy.
As ICH volume is known to increase within the first 3 hours following intracerebral hemorrhage, timely reversal is vital for patients on anticoagulation.
Investigators aimed to predict outcomes in patients with mild traumatic brain injury by identifying MRI features that are associated with clinical symptoms.